Search for more clinical trials
Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function
Conditions
Corpus Uteri Carcinoma
Conditions: official terms
Carcinoma - Uterine Neoplasms
Conditions: Keywords
carcinoma, uterus, Not metastatic
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Recruiting
Summary
Evaluate the toxicities of cervix and corpus uteri carcinomas treatment
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:
- Patients whose treatment is provided to Centre Oscar Lambret
- With a corpus uteri adenocarcinoma, no metastatic, treated by:
- Surgery and observation without complementary treatment or
- Surgery and adjuvant radiotherapy or
- Surgery and curietherapy of vaginal dome
- With a cervix carcinoma, stade IA2 to IIB proximal, treated by :
- External radiochemotherapy and curietherapy or
- Only surgery or
- Pre-surgical curietherapy and surgery
- Age > 18 years
- Patients whose treatment is provided to Centre Oscar Lambret
- With a corpus uteri adenocarcinoma, no metastatic, treated by:
- Surgery and observation without complementary treatment or
- Surgery and adjuvant radiotherapy or
- Surgery and curietherapy of vaginal dome
- With a cervix carcinoma, stade IA2 to IIB proximal, treated by :
- External radiochemotherapy and curietherapy or
- Only surgery or
- Pre-surgical curietherapy and surgery
- Age > 18 years
Location
Centre Oscar Lambret
Lille, France
Status: Recruiting
Contact: Philippe NICKERS, PhD - p-nickers@o-lambret.fr
Start Date
May 2009
Completion Date
December 2015
Sponsors
Centre Oscar Lambret
Source
Centre Oscar Lambret
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page